Search

Search Constraints

You searched for: Author/Creator Petersson, Joel

Search Results

1. A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients With Ulcerative Colitis, Using the Pictorial Representation of Illness and Self-measure Tool. (29th July 2020)

2. A Treat to Target Approach Decreases the Rate of CD‐Related Adverse Outcomes versus a Clinical Approach in Patients With Moderate to Severely Active Crohn's Disease: Data From CALM2017 ACG Governors Award for Excellence in Clinical Research: 598. (October 2017)

3. Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry. Issue 9 (20th August 2019)

4. Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry. Issue 9 (8th February 2019)

5. Adalimumab Long‐term Effectiveness in Adalimumab‐Naive Patients With Crohn's Disease: Final Data From PYRAMID Registry: 657. (October 2017)

6. Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn's Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE Trials. (25th April 2018)

8. Correlation Between Endoscopic and Histological Activity in Adults with Moderate to Severe Crohn's Disease: Data from EXTEND: 2016 ACG Presidential Poster Award: 739. (October 2016)

9. Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA. (17th July 2017)

10. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. Issue 10114 (23rd December 2017)